Therefore, TRPC6 is likely to be a target for amplification that confers enhanced invasive behavior to HNSCC cells and, therefore, may be a promising therapeutic target in the treatment of HNSCC. This evidence concerns the gene TRPC6 and head and neck squamous cell carcinoma.